BCM Gastroenterology & Hepatology Board Review Course 2023

Needs Statement

A course designed for physicians, trainees, and allied health professionals with interest or clinical practice in Gastroenterology and Hepatology. This course will serve as an update on latest diagnostic and therapeutic issues in GI and Hepatology. This program has been developed using a combination of lecture and case based curriculum designed to serve as an intensive review tool for GI and Hepatology Board Certification/Re-Certification Examination in 2023.

Educational Objectives

At the conclusion of the conference, participants should be able to:

• Summarize the strategies for the management of IBS-D
• Discuss early detection of esophageal cancer and effective screening methods for high-risk patients
• Identify tailored approaches to optimizing medical therapy in inflammatory bowel disease
• Compare and contrast current therapy options for patients with viral hepatitis and drugs in the clinical development pipeline
• Develop the appropriate management strategies for non-alcoholic fatty liver disease in clinical practice
• Identify appropriate diagnostic testing and treatment for H. pylori infection
• Implement treatment algorithms for clarithromycin resistant H. pylori infection
• Determine the appropriate treatment for Hepatitis B patients based on the interpretations of Hepatitis B serologic testing results

Target Audience

Accreditation/Credit Designation

AMA PRA Category 1 Credit™

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credit™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.